$2.98
-0.065-2.13%
Last update: Nov 5, 9:58 AM
ARS Pharmaceuticals Inc
SPRYNASDAQ
The average analyst price target for ARS Pharmaceuticals is $27.50, 821.3% above the current price. Of 5 analysts, 5 rate it Buy. Targets range from $18 to $40. The latest change came on Aug 13, 2026, when Leerink Partners lowered its price target on ARS Pharmaceuticals from $24 to $18 and kept an Outperform rating.
Price Target Range — 8 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months
